GE HealthCare Technologies (GEHC) Income from Discontinued Operations (2022 - 2023)
GE HealthCare Technologies' (GEHC) quarterly Income from Discontinued Operations came in at -$4.0 million in Q3 2023, down 166.67% quarter-over-quarter from $6.0 million in Q4 2022.
Powered by 
Analysis
GE HealthCare Technologies (GEHC) Income from Discontinued Operations (2022 - 2023) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Income from Discontinued Operations for 2 consecutive years, with -$4.0 million the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Income from Discontinued Operations changed N/A year-over-year to -$4.0 million; the trailing twelve-month figure through Dec 2024 stood at -$4.0 million (down 300.0% YoY), and the FY2023 full-year result was -$4.0 million, down 122.22% from the prior year.
- Income from Discontinued Operations slipped to -$4.0 million in Q3 2023 per GEHC's latest filing, from $6.0 million in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at $12.0 million in Q2 2022 and bottomed at -$4.0 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | - |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 108,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -4.00 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Jun 30, 2022 | 12.00 Mn |